Michael R Hamblin, PhD

"Transcranial photobiomodulation therapy is a rapidly growing approach to treat numerous brain disorders including Alzheimer's disease, depression, autism and age-related cognitive decline. Neuronic has designed an easy-to-use near-infrared helmet for home use. It is entirely safe with no side-effects, sturdily constructed and represents good value for money."

Dr. Michael R. Hamblin is a leading global expert in photobiomodulation (PBM), near-infrared light therapy, and neuroscience, serving as a Scientific Advisor at Neuronic. With more than 840 peer-reviewed publications, an h-index exceeding 170, and over 130,000 citations, Dr. Hamblin is widely acknowledged as one of the foremost authorities in light-based therapeutic technologies. He has been honored with the Endre Mester Lifetime Achievement Award, the Dose Response Society Outstanding Career Award, and the inaugural WALT Ali Javan Award, and he holds fellowship status with SPIE (the International Society for Optics & Photonics).

Initially serving as Associate Professor of Dermatology at Harvard Medical School, Dr. Hamblin now holds the position of Distinguished Visiting Professor at the University of Johannesburg in South Africa, where he continues to drive pioneering research at the intersection of photomedicine, tissue engineering, and neuroscience. His research has focused on how red and near-infrared wavelengths interact with mitochondrial Complex IV (cytochrome c oxidase) to increase adenosine triphosphate (ATP) production, release nitric oxide, regulate reactive oxygen species (ROS), and activate downstream gene-expression pathways. This work underpins clinically-relevant applications in wound healing, neuroregeneration, brain injury recovery, cognitive enhancement and mood disorders.

At Neuronic, Dr. Hamblin provides strategic oversight for device innovation. He plays a key role in the advancement of the Neuradiant 1070 and the Neuronic LIGHT systems - state-of-the-art wearable helmets and devices designed for transcranial photobiomodulation and large-scale brain-health applications. His guidance ensures that Neuronic’s technologies adhere to rigorous scientific standards and translate into safe, effective tools for clinicians, therapists, and end users.

Dr. Hamblin is regularly invited to present at major international conferences on neuromodulation, optogenetics, and brain health, and he serves as Editor-in-Chief of Photobiomodulation, Photomedicine & Laser Surgery, shaping the research agenda for the field. His leadership and scholarship continue to influence the direction of neurotechnology, and he remains committed to one central mission: to make evidence-based light therapy accessible and impactful for individuals seeking cognitive resilience, brain-injury recovery, and optimized neurological performance.